Aortic Arch Aneurysm in Behçet Disease Successfully Treated with Infliximab

  • Nishiyama Taihei
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Kondo Yuya
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Okamoto Shota
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Terasaki Mayu
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Toko Hirofumi
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Yagishita Mizuki
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Takahashi Hiroyuki
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Yokosawa Masahiro
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Tsuboi Hiroto
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Matsumoto Isao
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Sumida Takayuki
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan

この論文をさがす

抄録

<p>Aortic arch aneurysm (AAA) is a rare involvement in Behçet disease (BD). It is often life-threatening, yet few reports related to the treatment of AAA have been published. We herein report a 27-year-old woman with AAA caused by vascular BD. She was initially treated with prednisolone 1 mg/kg/d. However, the inflammation had not subsided after three weeks, so infliximab (IFX) was added for relief. After IFX administration, the C-reactive protein level normalized, and computed tomography at three months after therapeutic intervention revealed that the aneurysm had disappeared. This case suggests that early induction of IFX might be effective for aortic aneurysm in BD. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 59 (8), 1087-1091, 2020-04-15

    一般社団法人 日本内科学会

参考文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ